The Chemours Company
CC · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1,495 | $1,615 | $1,368 | $1,394 |
| % Growth | -7.4% | 18.1% | -1.9% | – |
| Cost of Goods Sold | $1,260 | $1,337 | $1,132 | $1,121 |
| Gross Profit | $235 | $278 | $236 | $273 |
| % Margin | 15.7% | 17.2% | 17.3% | 19.6% |
| R&D Expenses | $26 | $28 | $27 | $26 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $123 | $169 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $105 | $178 | $8 | $3 |
| Operating Expenses | $131 | $206 | $158 | $198 |
| Operating Income | $104 | $72 | $78 | $75 |
| % Margin | 7% | 4.5% | 5.7% | 5.4% |
| Other Income/Exp. Net | -$53 | -$333 | $0 | -$66 |
| Pre-Tax Income | $51 | -$261 | $78 | $9 |
| Tax Expense | -$9 | $119 | $82 | $17 |
| Net Income | $60 | -$381 | -$4 | -$8 |
| % Margin | 4% | -23.6% | -0.3% | -0.6% |
| EPS | 0.399 | -2.54 | -0.027 | -0.053 |
| % Growth | 115.7% | -9,413.1% | 50% | – |
| EPS Diluted | 0.399 | -2.54 | -0.027 | -0.053 |
| Weighted Avg Shares Out | 150 | 150 | 150 | 150 |
| Weighted Avg Shares Out Dil | 150 | 150 | 150 | 150 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $68 | $66 | $66 | $67 |
| Depreciation & Amortization | $79 | $80 | $88 | $78 |
| EBITDA | $198 | $152 | $154 | $154 |
| % Margin | 13.2% | 9.4% | 11.3% | 11% |